---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-040453"
form_type: "8-K"
ticker: "MGX"
cik: "0001785279"
company_name: "Metagenomi Therapeutics, Inc."
filed_at: "2025-03-17T23:59:59+00:00"
generated_at: "2026-05-24T16:02:16.718874+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Metagenomi enters $75M at-the-market equity distribution agreement with Jefferies

## Summary
- Agreement with Jefferies to sell up to $75M of common stock via ATM offerings on Nasdaq.
- Company is not obligated to sell any shares; sales are at Metagenomi's sole discretion.
- Jefferies will receive a commission of up to 3.0% of gross proceeds from shares sold.
- Shares to be offered under a new S-3 registration statement filed March 17, 2025.
- No specific use of proceeds disclosed; proceeds may fund operations or R&D.

## SEC filing metadata
- accession: 0000950170-25-040453
- form_type: 8-K
- ticker: MGX
- cik: 0001785279
- company_name: Metagenomi Therapeutics, Inc.
- filed_at: 2025-03-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1785279/000095017025040453/0000950170-25-040453-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1785279/000095017025040453/mgx-20250317.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-040453
- JSON: https://secwatch.observer/filing/0000950170-25-040453.json
- Plain text: https://secwatch.observer/filing/0000950170-25-040453.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.